Metabolic network as a progression biomarker of premanifest Huntington's disease
Background. The evaluation of effective disease-modifying therapies for neurodegenerative disorders relies on objective and accurate measures of progression in at-risk individuals. Here we used a computational approach to identify a functional brain network associated with the progression of preclin...
Saved in:
Published in | The Journal of clinical investigation Vol. 123; no. 9; pp. 4076 - 4096 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Society for Clinical Investigation
01.09.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!